The present invention relates to compounds having the structure formula (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
本发明涉及具有结构式(I)的化合物,其作为钾通道抑制剂用于治疗心律失常等。
EP1667977A4
申请人:——
公开号:EP1667977A4
公开(公告)日:2009-09-09
ISOQUINOLINONE POTASSIUM CHANNEL INHIBITORS
申请人:Merck & Co., Inc.
公开号:EP1667977A1
公开(公告)日:2006-06-14
US7781457B2
申请人:——
公开号:US7781457B2
公开(公告)日:2010-08-24
[EN] ISOQUINOLINONE POTASSIUM CHANNEL INHIBITORS<br/>[FR] INHIBITEURS DE CANAL POTASSIQUE D'ISOQUINOLINE
申请人:MERCK & CO INC
公开号:WO2005030727A1
公开(公告)日:2005-04-07
The present invention relates to compounds having the structure formula(I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.